RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Proteomics International Laboratories Stock

Proteomics International Laboratories Equity 2024

Proteomics International Laboratories Equity

9.41 M AUD

Ticker

PIQ.AX

ISIN

AU000000PIQ0

In 2024, Proteomics International Laboratories's equity was 9.41 M AUD, a 177.34% increase from the 3.39 M AUD equity in the previous year.

Proteomics International Laboratories Aktienanalyse

What does Proteomics International Laboratories do?

Proteomics International Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Proteomics International Laboratories's Equity

Proteomics International Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Proteomics International Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Proteomics International Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Proteomics International Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Proteomics International Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Proteomics International Laboratories stock

What is the equity of Proteomics International Laboratories this year?

Proteomics International Laboratories has equity of 9.41 M AUD this year.

What was the equity of Proteomics International Laboratories compared to the previous year?

The equity of Proteomics International Laboratories has increased/decreased by 177.34% increased compared to the previous year.

What impact does a high equity have on investors of Proteomics International Laboratories?

A high equity is advantageous for investors of Proteomics International Laboratories as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Proteomics International Laboratories?

A low equity can be a risk for investors of Proteomics International Laboratories, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Proteomics International Laboratories affect the company?

An increase in equity of Proteomics International Laboratories can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Proteomics International Laboratories affect the company?

A reduction in equity of Proteomics International Laboratories can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Proteomics International Laboratories?

Some factors that can affect the equity of Proteomics International Laboratories include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Proteomics International Laboratories so important for investors?

The equity of Proteomics International Laboratories is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Proteomics International Laboratories take to change the equity?

To change equity, Proteomics International Laboratories can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Proteomics International Laboratories pay?

Over the past 12 months, Proteomics International Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Proteomics International Laboratories is expected to pay a dividend of 0 AUD.

What is the dividend yield of Proteomics International Laboratories?

The current dividend yield of Proteomics International Laboratories is .

When does Proteomics International Laboratories pay dividends?

Proteomics International Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Proteomics International Laboratories?

Proteomics International Laboratories paid dividends every year for the past 0 years.

What is the dividend of Proteomics International Laboratories?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Proteomics International Laboratories located?

Proteomics International Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Proteomics International Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Proteomics International Laboratories from 11/3/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did Proteomics International Laboratories pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of Proteomics International Laboratories in the year 2023?

In the year 2023, Proteomics International Laboratories distributed 0 AUD as dividends.

In which currency does Proteomics International Laboratories pay out the dividend?

The dividends of Proteomics International Laboratories are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Proteomics International Laboratories

Our stock analysis for Proteomics International Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Proteomics International Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.